Gene Symbol | Gene ID | Gene Info |
---|---|---|
Etv1
|
ENSMUSG00000004151.10 | ets variant 1 |
Etv5
|
ENSMUSG00000013089.9 | ets variant 5 |
Gabpa
|
ENSMUSG00000008976.10 | GA repeat binding protein, alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_38843643_38844079 | Etv1 | 6463 | 0.214209 | -0.37 | 5.2e-03 | Click! |
chr12_38777570_38777721 | Etv1 | 1735 | 0.399656 | -0.30 | 2.5e-02 | Click! |
chr12_38844083_38844275 | Etv1 | 6781 | 0.212143 | -0.19 | 1.6e-01 | Click! |
chr12_38777375_38777547 | Etv1 | 1919 | 0.372333 | -0.18 | 1.8e-01 | Click! |
chr12_38778273_38778468 | Etv1 | 1010 | 0.588045 | -0.12 | 4.0e-01 | Click! |
chr16_22439541_22440261 | Etv5 | 182 | 0.948164 | 0.79 | 7.3e-13 | Click! |
chr16_22440302_22440492 | Etv5 | 678 | 0.697289 | 0.48 | 1.8e-04 | Click! |
chr16_22461208_22461359 | Etv5 | 21564 | 0.144402 | -0.48 | 2.5e-04 | Click! |
chr16_22438725_22439530 | Etv5 | 443 | 0.828623 | 0.43 | 9.2e-04 | Click! |
chr16_22395287_22395446 | Etv5 | 6463 | 0.210380 | -0.42 | 1.4e-03 | Click! |
chr16_84875745_84875916 | Gabpa | 15785 | 0.141613 | 0.10 | 4.8e-01 | Click! |
chr16_84876176_84876343 | Gabpa | 16214 | 0.140998 | 0.07 | 6.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_112695608_112695943 | 46.54 |
Gm18883 |
predicted gene, 18883 |
3904 |
0.16 |
chr3_134339308_134339650 | 30.86 |
Gm43558 |
predicted gene 43558 |
17813 |
0.17 |
chr18_12128256_12128787 | 20.94 |
Riok3 |
RIO kinase 3 |
220 |
0.92 |
chr18_62548232_62549066 | 19.47 |
Fbxo38 |
F-box protein 38 |
35 |
0.78 |
chr13_119462619_119462810 | 17.22 |
4833420G17Rik |
RIKEN cDNA 4833420G17 gene |
54 |
0.96 |
chr13_59823073_59823589 | 16.30 |
Gm34961 |
predicted gene, 34961 |
65 |
0.66 |
chr3_108146059_108146252 | 15.48 |
Gnai3 |
guanine nucleotide binding protein (G protein), alpha inhibiting 3 |
9 |
0.95 |
chr2_91649940_91650304 | 15.25 |
Arhgap1 |
Rho GTPase activating protein 1 |
4 |
0.82 |
chr1_74235993_74236513 | 14.82 |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
169 |
0.9 |
chr6_120363997_120364179 | 14.62 |
Kdm5a |
lysine (K)-specific demethylase 5A |
36 |
0.78 |
chr3_100162341_100162550 | 14.45 |
Wdr3 |
WD repeat domain 3 |
38 |
0.52 |
chr10_120226736_120227138 | 14.16 |
Llph |
LLP homolog, long-term synaptic facilitation (Aplysia) |
133 |
0.95 |
chr2_18392704_18393354 | 13.99 |
Dnajc1 |
DnaJ heat shock protein family (Hsp40) member C1 |
199 |
0.96 |
chr1_43933498_43933757 | 13.93 |
Tpp2 |
tripeptidyl peptidase II |
20 |
0.97 |
chr8_25785455_25785642 | 13.87 |
Lsm1 |
LSM1 homolog, mRNA degradation associated |
11 |
0.77 |
chr15_10485915_10486089 | 13.73 |
Rad1 |
RAD1 checkpoint DNA exonuclease |
16 |
0.52 |
chr11_20915147_20915637 | 13.62 |
Gm23681 |
predicted gene, 23681 |
22309 |
0.18 |
chr18_60774530_60774719 | 13.41 |
Rps14 |
ribosomal protein S14 |
28 |
0.96 |
chr5_138084988_138085604 | 13.03 |
Zkscan1 |
zinc finger with KRAB and SCAN domains 1 |
176 |
0.88 |
chr18_24121778_24122127 | 13.03 |
Ino80c |
INO80 complex subunit C |
1 |
0.98 |
chr8_83657028_83657233 | 12.84 |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
4432 |
0.12 |
chr8_86623521_86624089 | 12.67 |
Lonp2 |
lon peptidase 2, peroxisomal |
238 |
0.92 |
chr12_87266613_87266806 | 12.44 |
Ahsa1 |
AHA1, activator of heat shock protein ATPase 1 |
1 |
0.61 |
chr9_114639997_114640489 | 12.27 |
Cnot10 |
CCR4-NOT transcription complex, subunit 10 |
59 |
0.97 |
chr11_101442091_101442479 | 11.80 |
Rpl27 |
ribosomal protein L27 |
13 |
0.93 |
chr1_82724787_82724971 | 11.80 |
Mff |
mitochondrial fission factor |
11 |
0.75 |
chr12_78861495_78861819 | 11.58 |
Atp6v1d |
ATPase, H+ transporting, lysosomal V1 subunit D |
19 |
0.67 |
chr11_107417344_107417562 | 11.54 |
Gm11713 |
predicted gene 11713 |
7063 |
0.14 |
chr10_22730737_22731547 | 11.53 |
AC166256.1 |
novel protein |
95 |
0.67 |
chr18_32240189_32240660 | 11.51 |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
70 |
0.98 |
chr10_84622193_84622418 | 11.41 |
Polr3b |
polymerase (RNA) III (DNA directed) polypeptide B |
12 |
0.79 |
chr18_36783049_36783284 | 11.37 |
Hars |
histidyl-tRNA synthetase |
39 |
0.51 |
chr11_31870642_31870991 | 11.23 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
1395 |
0.45 |
chrX_169320012_169320582 | 11.17 |
Hccs |
holocytochrome c synthetase |
3 |
0.84 |
chr18_56975212_56975450 | 11.16 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
23 |
0.98 |
chr2_23068062_23068258 | 11.14 |
Acbd5 |
acyl-Coenzyme A binding domain containing 5 |
7 |
0.98 |
chr6_136468328_136469393 | 11.12 |
Gm6728 |
predicted gene 6728 |
18326 |
0.12 |
chr11_4895204_4895819 | 11.10 |
Thoc5 |
THO complex 5 |
168 |
0.92 |
chr8_113635691_113635888 | 10.98 |
Mon1b |
MON1 homolog B, secretory traffciking associated |
46 |
0.97 |
chr8_70522463_70523590 | 10.95 |
Kxd1 |
KxDL motif containing 1 |
64 |
0.93 |
chr6_125008651_125009067 | 10.93 |
Zfp384 |
zinc finger protein 384 |
286 |
0.78 |
chr16_38522153_38522880 | 10.90 |
Timmdc1 |
translocase of inner mitochondrial membrane domain containing 1 |
125 |
0.94 |
chr4_3574782_3574963 | 10.81 |
Tgs1 |
trimethylguanosine synthase 1 |
3 |
0.5 |
chr13_41000869_41001065 | 10.80 |
Pak1ip1 |
PAK1 interacting protein 1 |
56 |
0.67 |
chr2_130667648_130667858 | 10.71 |
Itpa |
inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
52 |
0.95 |
chr2_130179305_130179484 | 10.64 |
Snrpb |
small nuclear ribonucleoprotein B |
9 |
0.97 |
chr10_76468807_76469203 | 10.59 |
Mcm3ap |
minichromosome maintenance complex component 3 associated protein |
78 |
0.53 |
chr1_37872111_37872495 | 10.52 |
Lipt1 |
lipoyltransferase 1 |
71 |
0.95 |
chr12_4234250_4234437 | 10.49 |
Cenpo |
centromere protein O |
49 |
0.8 |
chr6_100399458_100399609 | 10.48 |
Gm23234 |
predicted gene, 23234 |
95281 |
0.06 |
chr16_30587494_30587679 | 10.44 |
Lsg1 |
large 60S subunit nuclear export GTPase 1 |
3 |
0.98 |
chr2_129297091_129297464 | 10.43 |
Ckap2l |
cytoskeleton associated protein 2-like |
65 |
0.52 |
chr1_172082628_172082857 | 10.43 |
Ncstn |
nicastrin |
53 |
0.5 |
chr2_5844885_5845076 | 10.41 |
Cdc123 |
cell division cycle 123 |
39 |
0.49 |
chr12_31499504_31499691 | 10.34 |
Cbll1 |
Casitas B-lineage lymphoma-like 1 |
19 |
0.95 |
chr17_6827812_6828565 | 10.31 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
19679 |
0.14 |
chr4_41124245_41124598 | 10.28 |
Nol6 |
nucleolar protein family 6 (RNA-associated) |
34 |
0.95 |
chrX_134058473_134059405 | 10.23 |
Cstf2 |
cleavage stimulation factor, 3' pre-RNA subunit 2 |
248 |
0.9 |
chr17_21449784_21450734 | 10.23 |
Gm49691 |
predicted gene, 49691 |
8 |
0.6 |
chr11_29526267_29526597 | 10.18 |
Mtif2 |
mitochondrial translational initiation factor 2 |
4 |
0.96 |
chr3_5576073_5576506 | 10.07 |
Pex2 |
peroxisomal biogenesis factor 2 |
50 |
0.99 |
chr2_121473954_121474145 | 10.05 |
Mfap1b |
microfibrillar-associated protein 1B |
18 |
0.94 |
chr4_155831478_155831692 | 10.01 |
Aurkaip1 |
aurora kinase A interacting protein 1 |
34 |
0.92 |
chr11_48816528_48817196 | 10.00 |
Trim41 |
tripartite motif-containing 41 |
91 |
0.93 |
chr17_33909147_33909546 | 9.99 |
BC051226 |
cDNA sequence BC051226 |
29 |
0.51 |
chr2_30952783_30953056 | 9.87 |
Tor1b |
torsin family 1, member B |
40 |
0.96 |
chr2_129129245_129130482 | 9.86 |
Chchd5 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
13 |
0.96 |
chr6_112696037_112696506 | 9.85 |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
333 |
0.91 |
chr13_21440578_21441195 | 9.84 |
Pgbd1 |
piggyBac transposable element derived 1 |
15 |
0.84 |
chr5_76529162_76529343 | 9.82 |
Exoc1 |
exocyst complex component 1 |
59 |
0.98 |
chr19_31082675_31083075 | 9.82 |
Cstf2t |
cleavage stimulation factor, 3' pre-RNA subunit 2, tau |
38 |
0.99 |
chr7_127876795_127876993 | 9.82 |
Zfp668 |
zinc finger protein 668 |
66 |
0.52 |
chr13_14039294_14039770 | 9.73 |
Tbce |
tubulin-specific chaperone E |
47 |
0.95 |
chr6_29609802_29609995 | 9.61 |
Tnpo3 |
transportin 3 |
11 |
0.98 |
chr8_72219605_72219798 | 9.59 |
Fam32a |
family with sequence similarity 32, member A |
29 |
0.95 |
chr17_46327911_46328132 | 9.58 |
Abcc10 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
2 |
0.96 |
chr6_8258816_8259363 | 9.56 |
Rpa3 |
replication protein A3 |
51 |
0.63 |
chr4_155803471_155804037 | 9.52 |
Mrpl20 |
mitochondrial ribosomal protein L20 |
5 |
0.93 |
chr15_78934769_78934982 | 9.52 |
Nol12 |
nucleolar protein 12 |
58 |
0.93 |
chr8_11497413_11497616 | 9.50 |
Naxd |
NAD(P)HX dehydratase |
8 |
0.96 |
chrX_166170282_166170486 | 9.46 |
Gemin8 |
gem nuclear organelle associated protein 8 |
70 |
0.98 |
chr5_29434579_29434781 | 9.46 |
Nom1 |
nucleolar protein with MIF4G domain 1 |
16 |
0.98 |
chr9_64737668_64737846 | 9.44 |
Rab11a |
RAB11A, member RAS oncogene family |
1 |
0.98 |
chr8_84699845_84700485 | 9.40 |
Trmt1 |
tRNA methyltransferase 1 |
984 |
0.3 |
chr4_122885578_122886044 | 9.40 |
Cap1 |
CAP, adenylate cyclase-associated protein 1 (yeast) |
49 |
0.97 |
chr3_115642021_115642675 | 9.40 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
72724 |
0.1 |
chr6_40471216_40471539 | 9.39 |
Ssbp1 |
single-stranded DNA binding protein 1 |
25 |
0.96 |
chr2_74825700_74825911 | 9.38 |
Mtx2 |
metaxin 2 |
2 |
0.96 |
chr9_108648841_108649511 | 9.38 |
Arih2 |
ariadne RBR E3 ubiquitin protein ligase 2 |
142 |
0.9 |
chr8_46163265_46163993 | 9.36 |
Cfap97 |
cilia and flagella associated protein 97 |
22 |
0.95 |
chr5_139775212_139775893 | 9.24 |
Ints1 |
integrator complex subunit 1 |
86 |
0.95 |
chrX_134585187_134585722 | 9.24 |
Rpl36a |
ribosomal protein L36A |
200 |
0.88 |
chr1_9744957_9745108 | 9.14 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
2616 |
0.2 |
chr1_58445436_58445649 | 9.13 |
Ppil3 |
peptidylprolyl isomerase (cyclophilin)-like 3 |
56 |
0.53 |
chr1_87213816_87214005 | 9.13 |
Eif4e2 |
eukaryotic translation initiation factor 4E member 2 |
4 |
0.96 |
chr19_32485724_32486055 | 9.12 |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
34 |
0.49 |
chr2_91649672_91649851 | 9.11 |
Zfp408 |
zinc finger protein 408 |
1 |
0.58 |
chr10_41449773_41450754 | 9.08 |
Zbtb24 |
zinc finger and BTB domain containing 24 |
120 |
0.94 |
chr3_32708861_32709461 | 9.05 |
Actl6a |
actin-like 6A |
3 |
0.97 |
chr11_107417035_107417241 | 9.05 |
Gm11713 |
predicted gene 11713 |
6748 |
0.14 |
chr19_8920277_8920899 | 9.02 |
B3gat3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
104 |
0.88 |
chr2_30828228_30828651 | 9.01 |
Asb6 |
ankyrin repeat and SOCS box-containing 6 |
148 |
0.93 |
chr6_136828152_136828539 | 9.00 |
Wbp11 |
WW domain binding protein 11 |
112 |
0.76 |
chr2_29060113_29060310 | 8.98 |
Ttf1 |
transcription termination factor, RNA polymerase I |
51 |
0.97 |
chr15_25983914_25984499 | 8.98 |
Zfp622 |
zinc finger protein 622 |
160 |
0.96 |
chr17_86145102_86145283 | 8.90 |
Srbd1 |
S1 RNA binding domain 1 |
17 |
0.98 |
chr5_143817571_143817892 | 8.89 |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
57 |
0.97 |
chr15_8444593_8444771 | 8.84 |
Nipbl |
NIPBL cohesin loading factor |
219 |
0.93 |
chr10_61452755_61453085 | 8.84 |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
259 |
0.84 |
chr2_84678018_84678455 | 8.82 |
Tmx2 |
thioredoxin-related transmembrane protein 2 |
118 |
0.41 |
chr7_140856176_140856523 | 8.75 |
Gm45785 |
predicted gene 45785 |
18 |
0.47 |
chr6_148896057_148896563 | 8.71 |
Caprin2 |
caprin family member 2 |
73 |
0.95 |
chr9_102626465_102626647 | 8.68 |
Cep63 |
centrosomal protein 63 |
22 |
0.59 |
chrX_105069986_105070282 | 8.67 |
5530601H04Rik |
RIKEN cDNA 5530601H04 gene |
10 |
0.97 |
chr17_24936908_24937105 | 8.65 |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
29 |
0.95 |
chr2_167015159_167015414 | 8.60 |
Ddx27 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 |
24 |
0.96 |
chr7_16783087_16783733 | 8.60 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
1012 |
0.38 |
chr16_21332982_21333472 | 8.57 |
Magef1 |
melanoma antigen family F, 1 |
98 |
0.97 |
chr8_91133987_91134485 | 8.56 |
Aktip |
thymoma viral proto-oncogene 1 interacting protein |
209 |
0.89 |
chr2_157367487_157367721 | 8.55 |
Manbal |
mannosidase, beta A, lysosomal-like |
10 |
0.97 |
chr4_32862579_32862778 | 8.54 |
Ankrd6 |
ankyrin repeat domain 6 |
1995 |
0.32 |
chr1_161968669_161969306 | 8.54 |
4930558K02Rik |
RIKEN cDNA 4930558K02 gene |
161 |
0.39 |
chr7_64057919_64058310 | 8.53 |
Gm20670 |
predicted gene 20670 |
512 |
0.76 |
chr12_85110707_85110908 | 8.53 |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
26 |
0.51 |
chr6_125192079_125192266 | 8.52 |
Mrpl51 |
mitochondrial ribosomal protein L51 |
7 |
0.85 |
chr19_8941688_8942280 | 8.52 |
Mta2 |
metastasis-associated gene family, member 2 |
109 |
0.87 |
chrX_101532388_101532883 | 8.51 |
Taf1 |
TATA-box binding protein associated factor 1 |
99 |
0.96 |
chr11_6200090_6200270 | 8.51 |
A730071L15Rik |
RIKEN cDNA A730071L15Rik gene |
151 |
0.6 |
chr11_29514972_29515287 | 8.49 |
Gm12089 |
predicted gene 12089 |
43 |
0.55 |
chr2_121008071_121008912 | 8.48 |
Ccndbp1 |
cyclin D-type binding-protein 1 |
19 |
0.96 |
chr5_142920749_142921092 | 8.47 |
Actb |
actin, beta |
14166 |
0.14 |
chr4_116074998_116075178 | 8.47 |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
17 |
0.69 |
chr8_69901343_69901862 | 8.46 |
Tssk6 |
testis-specific serine kinase 6 |
582 |
0.43 |
chrX_7722096_7722503 | 8.45 |
Wdr45 |
WD repeat domain 45 |
23 |
0.51 |
chr4_126753695_126753910 | 8.42 |
AU040320 |
expressed sequence AU040320 |
8 |
0.85 |
chr11_4986650_4987004 | 8.41 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
3 |
0.97 |
chr11_78772009_78772185 | 8.37 |
Gm23840 |
predicted gene, 23840 |
17575 |
0.14 |
chr14_63543277_63544100 | 8.36 |
Mtmr9 |
myotubularin related protein 9 |
294 |
0.89 |
chr15_58933660_58933845 | 8.36 |
Ndufb9 |
NADH:ubiquinone oxidoreductase subunit B9 |
4 |
0.49 |
chr13_38037104_38037296 | 8.35 |
Riok1 |
RIO kinase 1 |
45 |
0.61 |
chr18_75005682_75005966 | 8.32 |
BC031181 |
cDNA sequence BC031181 |
44 |
0.71 |
chr11_44470159_44471042 | 8.31 |
Ublcp1 |
ubiquitin-like domain containing CTD phosphatase 1 |
102 |
0.95 |
chr13_17695267_17695523 | 8.30 |
Mplkip |
M-phase specific PLK1 intereacting protein |
18 |
0.66 |
chr3_79591274_79591475 | 8.29 |
Ppid |
peptidylprolyl isomerase D (cyclophilin D) |
9 |
0.96 |
chr11_104425117_104425292 | 8.24 |
Gm47315 |
predicted gene, 47315 |
96 |
0.97 |
chrX_151017171_151017501 | 8.20 |
Gnl3l |
guanine nucleotide binding protein-like 3 (nucleolar)-like |
14 |
0.97 |
chr2_140066689_140066983 | 8.19 |
Tasp1 |
taspase, threonine aspartase 1 |
31 |
0.98 |
chr19_10577328_10577985 | 8.16 |
Cyb561a3 |
cytochrome b561 family, member A3 |
165 |
0.64 |
chrX_51018779_51019209 | 8.11 |
Rap2c |
RAP2C, member of RAS oncogene family |
976 |
0.6 |
chr5_145280282_145280554 | 8.10 |
Zscan25 |
zinc finger and SCAN domain containing 25 |
82 |
0.95 |
chr10_75517735_75518057 | 8.09 |
Gucd1 |
guanylyl cyclase domain containing 1 |
10 |
0.6 |
chr10_89732217_89732418 | 8.07 |
Actr6 |
ARP6 actin-related protein 6 |
22 |
0.98 |
chr1_87755659_87756078 | 8.07 |
Atg16l1 |
autophagy related 16-like 1 (S. cerevisiae) |
2 |
0.97 |
chr1_55130962_55131995 | 8.07 |
Mob4 |
MOB family member 4, phocein |
152 |
0.92 |
chr17_20944797_20945472 | 8.06 |
Gm49761 |
predicted gene, 49761 |
15 |
0.68 |
chr5_100416089_100416865 | 8.04 |
Sec31a |
Sec31 homolog A (S. cerevisiae) |
243 |
0.9 |
chr12_84285172_84285857 | 8.03 |
Ptgr2 |
prostaglandin reductase 2 |
101 |
0.95 |
chr7_143600011_143600648 | 8.03 |
Gm15579 |
predicted gene 15579 |
195 |
0.53 |
chr15_101284186_101284373 | 8.00 |
Atg101 |
autophagy related 101 |
7 |
0.95 |
chr6_124740514_124741215 | 8.00 |
Grcc10 |
gene rich cluster, C10 gene |
149 |
0.71 |
chr10_57532439_57532643 | 8.00 |
Serinc1 |
serine incorporator 1 |
11 |
0.98 |
chr19_7017655_7018362 | 7.98 |
Fermt3 |
fermitin family member 3 |
1337 |
0.22 |
chr1_84838599_84839208 | 7.98 |
Trip12 |
thyroid hormone receptor interactor 12 |
172 |
0.89 |
chr14_54686822_54687317 | 7.97 |
1700123O20Rik |
RIKEN cDNA 1700123O20 gene |
25 |
0.62 |
chr5_31613849_31614298 | 7.97 |
Mrpl33 |
mitochondrial ribosomal protein L33 |
56 |
0.55 |
chr4_141078239_141078590 | 7.96 |
Necap2 |
NECAP endocytosis associated 2 |
57 |
0.95 |
chr6_113046036_113046851 | 7.91 |
Thumpd3 |
THUMP domain containing 3 |
15 |
0.8 |
chr4_86857284_86857567 | 7.89 |
Rps6 |
ribosomal protein S6 |
13 |
0.98 |
chr9_96719374_96720083 | 7.87 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
122 |
0.96 |
chr4_132638904_132639140 | 7.87 |
Eya3 |
EYA transcriptional coactivator and phosphatase 3 |
24 |
0.97 |
chr3_87565774_87566453 | 7.87 |
ETV3L |
ets variant 3-like |
14864 |
0.14 |
chr5_145231556_145231834 | 7.86 |
Zfp655 |
zinc finger protein 655 |
20 |
0.96 |
chr10_40246959_40247148 | 7.85 |
Rpf2 |
ribosome production factor 2 homolog |
17 |
0.96 |
chr1_153748199_153748915 | 7.84 |
Gm28513 |
predicted gene 28513 |
767 |
0.34 |
chr9_106160061_106160250 | 7.84 |
Glyctk |
glycerate kinase |
2017 |
0.15 |
chr12_80115646_80115869 | 7.84 |
1300014J16Rik |
RIKEN cDNA 1300014J16 gene |
106 |
0.94 |
chr3_146521363_146521539 | 7.83 |
Rpf1 |
ribosome production factor 1 homolog |
22 |
0.97 |
chr19_21127455_21127646 | 7.82 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
22840 |
0.2 |
chr4_150914349_150914730 | 7.81 |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
23 |
0.58 |
chr3_65958052_65958719 | 7.77 |
Ccnl1 |
cyclin L1 |
136 |
0.85 |
chr10_13982761_13983386 | 7.77 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr9_7184427_7184626 | 7.76 |
Dcun1d5 |
DCN1, defective in cullin neddylation 1, domain containing 5 (S. cerevisiae) |
6 |
0.56 |
chr19_12009544_12009742 | 7.76 |
Olfr1421-ps1 |
olfactory receptor 1421, pseudogene 1 |
10532 |
0.08 |
chr4_34614837_34615291 | 7.76 |
Rars2 |
arginyl-tRNA synthetase 2, mitochondrial |
86 |
0.54 |
chr14_60251795_60251971 | 7.76 |
Gm49336 |
predicted gene, 49336 |
376 |
0.52 |
chr4_108999952_109000283 | 7.74 |
Nrd1 |
nardilysin, N-arginine dibasic convertase, NRD convertase 1 |
538 |
0.63 |
chr4_121097729_121098495 | 7.73 |
Zmpste24 |
zinc metallopeptidase, STE24 |
129 |
0.92 |
chr9_119322645_119323231 | 7.70 |
Oxsr1 |
oxidative-stress responsive 1 |
511 |
0.68 |
chr5_21786615_21787081 | 7.70 |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
1565 |
0.25 |
chr1_164275492_164275698 | 7.69 |
Ccdc181 |
coiled-coil domain containing 181 |
10 |
0.97 |
chr13_55321901_55322102 | 7.69 |
Prelid1 |
PRELI domain containing 1 |
18 |
0.52 |
chr11_93967995_93968741 | 7.66 |
Gm20390 |
predicted gene 20390 |
75 |
0.52 |
chr4_155601762_155602277 | 7.64 |
Slc35e2 |
solute carrier family 35, member E2 |
75 |
0.94 |
chr9_35123939_35124137 | 7.64 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
4770 |
0.15 |
chr16_62787051_62787243 | 7.63 |
Nsun3 |
NOL1/NOP2/Sun domain family member 3 |
329 |
0.87 |
chrX_104413172_104414008 | 7.61 |
Abcb7 |
ATP-binding cassette, sub-family B (MDR/TAP), member 7 |
256 |
0.93 |
chr14_70153676_70154230 | 7.59 |
Ccar2 |
cell cycle activator and apoptosis regulator 2 |
142 |
0.93 |
chr3_137957854_137958255 | 7.58 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
2187 |
0.2 |
chr10_5823394_5824846 | 7.58 |
Mtrf1l |
mitochondrial translational release factor 1-like |
210 |
0.95 |
chr8_126970959_126971298 | 7.57 |
Rbm34 |
RNA binding motif protein 34 |
57 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | GO:0019086 | late viral transcription(GO:0019086) |
6.7 | 20.2 | GO:0030242 | pexophagy(GO:0030242) |
5.8 | 17.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
5.7 | 17.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
5.0 | 20.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
5.0 | 15.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
4.8 | 19.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
4.7 | 18.7 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
4.7 | 14.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
4.6 | 23.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
4.6 | 13.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
4.5 | 8.9 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
4.5 | 8.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
4.4 | 13.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
4.4 | 13.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
4.4 | 13.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
4.3 | 12.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.1 | 8.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
4.0 | 16.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
4.0 | 11.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
3.9 | 11.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.9 | 11.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
3.8 | 11.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
3.8 | 15.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
3.8 | 22.5 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
3.8 | 11.3 | GO:0061010 | gall bladder development(GO:0061010) |
3.7 | 14.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
3.7 | 11.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
3.6 | 14.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
3.6 | 14.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
3.6 | 14.4 | GO:0051031 | tRNA transport(GO:0051031) |
3.6 | 7.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
3.6 | 10.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.6 | 14.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.5 | 10.6 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
3.5 | 10.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.5 | 10.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
3.5 | 10.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
3.5 | 14.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
3.5 | 13.8 | GO:0048478 | replication fork protection(GO:0048478) |
3.4 | 17.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
3.4 | 6.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
3.4 | 10.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
3.4 | 26.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
3.3 | 10.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
3.3 | 9.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
3.2 | 9.7 | GO:0036394 | amylase secretion(GO:0036394) |
3.2 | 3.2 | GO:0061724 | lipophagy(GO:0061724) |
3.2 | 6.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
3.2 | 6.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
3.2 | 22.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
3.1 | 6.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
3.1 | 9.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
3.1 | 3.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
3.1 | 12.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
3.1 | 15.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
3.1 | 12.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.1 | 9.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
3.1 | 9.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
3.1 | 18.6 | GO:0051013 | microtubule severing(GO:0051013) |
3.1 | 12.3 | GO:0090148 | membrane fission(GO:0090148) |
3.0 | 12.1 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
3.0 | 15.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
3.0 | 9.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
3.0 | 18.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
3.0 | 24.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
3.0 | 3.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
3.0 | 6.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
3.0 | 8.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.0 | 11.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.0 | 8.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.0 | 20.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.9 | 8.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.9 | 8.8 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
2.9 | 8.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.9 | 20.2 | GO:0006265 | DNA topological change(GO:0006265) |
2.9 | 8.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.9 | 77.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
2.8 | 17.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
2.8 | 11.4 | GO:0008228 | opsonization(GO:0008228) |
2.8 | 14.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.8 | 8.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.8 | 8.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
2.8 | 14.0 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
2.8 | 2.8 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
2.8 | 8.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.8 | 19.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
2.8 | 11.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
2.8 | 5.5 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.8 | 24.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
2.8 | 8.3 | GO:0030576 | Cajal body organization(GO:0030576) |
2.8 | 27.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
2.7 | 8.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
2.7 | 19.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
2.7 | 10.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
2.7 | 2.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.7 | 5.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
2.7 | 83.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
2.7 | 45.6 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
2.7 | 8.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
2.6 | 10.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.6 | 10.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
2.6 | 2.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
2.6 | 7.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.6 | 2.6 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
2.6 | 10.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.6 | 10.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
2.6 | 2.6 | GO:0019042 | viral latency(GO:0019042) |
2.6 | 15.6 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
2.6 | 12.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.6 | 5.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
2.6 | 12.9 | GO:0045006 | DNA deamination(GO:0045006) |
2.6 | 5.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.6 | 5.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.6 | 17.9 | GO:0016559 | peroxisome fission(GO:0016559) |
2.6 | 5.1 | GO:0045472 | response to ether(GO:0045472) |
2.6 | 7.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
2.5 | 5.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
2.5 | 5.1 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.5 | 5.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
2.5 | 7.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
2.5 | 7.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.5 | 5.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.5 | 15.0 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
2.5 | 37.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
2.5 | 12.4 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
2.5 | 7.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
2.5 | 12.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
2.5 | 14.8 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
2.5 | 2.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
2.5 | 17.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.4 | 2.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
2.4 | 17.0 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
2.4 | 7.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.4 | 2.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
2.4 | 7.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.4 | 4.8 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.4 | 9.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
2.4 | 12.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
2.4 | 14.4 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
2.4 | 4.8 | GO:0051665 | membrane raft localization(GO:0051665) |
2.4 | 14.4 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
2.4 | 14.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
2.4 | 14.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.4 | 4.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.4 | 7.2 | GO:0050904 | diapedesis(GO:0050904) |
2.4 | 7.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
2.4 | 21.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
2.4 | 7.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
2.4 | 45.3 | GO:0006301 | postreplication repair(GO:0006301) |
2.4 | 7.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.4 | 9.5 | GO:0046070 | dGTP metabolic process(GO:0046070) |
2.4 | 14.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
2.4 | 2.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.4 | 7.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
2.4 | 4.7 | GO:0040031 | snRNA modification(GO:0040031) |
2.3 | 4.7 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.3 | 7.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
2.3 | 2.3 | GO:0060914 | heart formation(GO:0060914) |
2.3 | 16.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
2.3 | 7.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
2.3 | 16.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
2.3 | 2.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.3 | 20.9 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
2.3 | 9.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
2.3 | 6.9 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.3 | 4.6 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
2.3 | 2.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
2.3 | 9.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
2.3 | 6.9 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
2.3 | 11.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
2.3 | 25.2 | GO:0031167 | rRNA methylation(GO:0031167) |
2.3 | 4.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.3 | 9.1 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.3 | 4.6 | GO:0002432 | granuloma formation(GO:0002432) |
2.3 | 13.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
2.3 | 6.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
2.3 | 6.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.3 | 15.9 | GO:0019081 | viral translation(GO:0019081) |
2.3 | 9.0 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
2.3 | 9.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
2.3 | 6.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.3 | 2.3 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.3 | 6.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.3 | 4.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.2 | 13.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
2.2 | 11.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.2 | 17.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
2.2 | 6.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.2 | 11.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
2.2 | 2.2 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.2 | 11.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.2 | 2.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
2.2 | 6.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
2.2 | 15.3 | GO:0033572 | transferrin transport(GO:0033572) |
2.2 | 6.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
2.2 | 17.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
2.2 | 13.1 | GO:0016266 | O-glycan processing(GO:0016266) |
2.2 | 6.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.2 | 6.5 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
2.2 | 6.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
2.1 | 21.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
2.1 | 10.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
2.1 | 6.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.1 | 6.4 | GO:0018343 | protein farnesylation(GO:0018343) |
2.1 | 10.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
2.1 | 15.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
2.1 | 6.4 | GO:0051182 | coenzyme transport(GO:0051182) |
2.1 | 14.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
2.1 | 2.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
2.1 | 6.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.1 | 2.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
2.1 | 6.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
2.1 | 4.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
2.1 | 6.3 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
2.1 | 2.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
2.1 | 6.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
2.1 | 2.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
2.1 | 14.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.1 | 2.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.1 | 12.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
2.1 | 6.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.1 | 4.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.1 | 8.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
2.1 | 52.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
2.1 | 29.1 | GO:0030488 | tRNA methylation(GO:0030488) |
2.1 | 18.7 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
2.1 | 8.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
2.1 | 8.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.1 | 14.4 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.1 | 18.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
2.1 | 6.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.1 | 4.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
2.0 | 79.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
2.0 | 6.1 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
2.0 | 2.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.0 | 10.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
2.0 | 6.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
2.0 | 6.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
2.0 | 6.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
2.0 | 2.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
2.0 | 4.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
2.0 | 6.0 | GO:1903416 | response to glycoside(GO:1903416) |
2.0 | 2.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.0 | 4.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.0 | 10.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.0 | 4.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
2.0 | 2.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.0 | 9.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.0 | 9.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
2.0 | 4.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
2.0 | 5.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.0 | 84.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
2.0 | 7.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
2.0 | 5.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
2.0 | 11.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.0 | 5.9 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.0 | 3.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
2.0 | 2.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.0 | 11.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
2.0 | 3.9 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.9 | 11.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.9 | 5.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.9 | 3.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.9 | 21.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.9 | 1.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.9 | 5.8 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.9 | 3.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.9 | 1.9 | GO:0048254 | snoRNA localization(GO:0048254) |
1.9 | 7.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.9 | 7.6 | GO:0045862 | positive regulation of proteolysis(GO:0045862) |
1.9 | 5.7 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
1.9 | 5.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.9 | 3.8 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.9 | 7.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.9 | 13.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.9 | 3.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.9 | 7.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.9 | 11.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.9 | 16.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.9 | 42.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
1.9 | 13.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.9 | 13.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.9 | 5.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.9 | 27.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.9 | 1.9 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
1.9 | 9.3 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
1.9 | 3.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.8 | 1.8 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.8 | 1.8 | GO:1902946 | protein localization to early endosome(GO:1902946) |
1.8 | 5.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.8 | 3.7 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.8 | 5.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.8 | 7.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.8 | 9.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.8 | 5.5 | GO:0009211 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.8 | 7.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.8 | 9.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.8 | 3.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.8 | 5.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.8 | 5.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.8 | 3.6 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.8 | 9.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.8 | 7.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.8 | 16.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.8 | 1.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
1.8 | 7.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.8 | 9.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.8 | 10.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.8 | 5.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.8 | 1.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.8 | 9.0 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.8 | 21.6 | GO:0045116 | protein neddylation(GO:0045116) |
1.8 | 9.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.8 | 7.2 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
1.8 | 5.4 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
1.8 | 8.9 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.8 | 5.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.8 | 3.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.8 | 21.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.8 | 26.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.8 | 45.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.8 | 14.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.8 | 5.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.8 | 1.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.7 | 8.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.7 | 3.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.7 | 29.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.7 | 8.7 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.7 | 3.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.7 | 29.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.7 | 10.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.7 | 5.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.7 | 8.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.7 | 12.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.7 | 5.2 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
1.7 | 6.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.7 | 1.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.7 | 5.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.7 | 6.9 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.7 | 10.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
1.7 | 1.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.7 | 3.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.7 | 34.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.7 | 10.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.7 | 6.8 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
1.7 | 5.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.7 | 1.7 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
1.7 | 13.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.7 | 36.8 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
1.7 | 3.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
1.7 | 1.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.7 | 20.1 | GO:0042026 | protein refolding(GO:0042026) |
1.7 | 13.3 | GO:0006266 | DNA ligation(GO:0006266) |
1.7 | 16.6 | GO:0016180 | snRNA processing(GO:0016180) |
1.7 | 14.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.7 | 13.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.7 | 3.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.7 | 11.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.7 | 5.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
1.7 | 1.7 | GO:0032252 | secretory granule localization(GO:0032252) |
1.7 | 6.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.6 | 19.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.6 | 4.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.6 | 3.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
1.6 | 3.3 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.6 | 29.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
1.6 | 4.9 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
1.6 | 6.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.6 | 6.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.6 | 8.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.6 | 6.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
1.6 | 6.5 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.6 | 3.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.6 | 4.9 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.6 | 11.4 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.6 | 17.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.6 | 6.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
1.6 | 1.6 | GO:0001555 | oocyte growth(GO:0001555) |
1.6 | 9.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.6 | 4.9 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.6 | 4.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.6 | 3.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.6 | 35.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
1.6 | 12.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
1.6 | 6.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.6 | 4.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.6 | 4.9 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.6 | 3.2 | GO:0043174 | purine ribonucleoside salvage(GO:0006166) nucleoside salvage(GO:0043174) |
1.6 | 16.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
1.6 | 1.6 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.6 | 25.7 | GO:0006414 | translational elongation(GO:0006414) |
1.6 | 6.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.6 | 4.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.6 | 6.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.6 | 3.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.6 | 6.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.6 | 4.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.6 | 7.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.6 | 31.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.6 | 180.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
1.6 | 30.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.6 | 4.8 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
1.6 | 4.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.6 | 7.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.6 | 4.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.6 | 1.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.6 | 3.2 | GO:0072718 | response to cisplatin(GO:0072718) |
1.6 | 6.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
1.6 | 1.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.6 | 4.7 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.6 | 18.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.6 | 6.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.6 | 14.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.6 | 14.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.6 | 1.6 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.6 | 3.1 | GO:0044321 | response to leptin(GO:0044321) |
1.6 | 6.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.6 | 9.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
1.5 | 6.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.5 | 6.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.5 | 4.6 | GO:1903232 | melanosome assembly(GO:1903232) |
1.5 | 3.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.5 | 7.7 | GO:0034063 | stress granule assembly(GO:0034063) |
1.5 | 7.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.5 | 4.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.5 | 1.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.5 | 9.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.5 | 9.2 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.5 | 6.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.5 | 9.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.5 | 10.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 12.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.5 | 3.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
1.5 | 3.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.5 | 16.6 | GO:0032392 | DNA geometric change(GO:0032392) |
1.5 | 3.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.5 | 7.5 | GO:1901660 | calcium ion export(GO:1901660) |
1.5 | 1.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.5 | 1.5 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.5 | 6.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.5 | 40.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.5 | 3.0 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
1.5 | 3.0 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.5 | 3.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.5 | 3.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.5 | 4.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.5 | 5.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.5 | 7.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.5 | 7.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.5 | 4.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.5 | 1.5 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.5 | 49.6 | GO:0009060 | aerobic respiration(GO:0009060) |
1.5 | 1.5 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.5 | 4.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.4 | 24.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.4 | 17.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.4 | 1.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
1.4 | 4.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.4 | 4.3 | GO:0042891 | antibiotic transport(GO:0042891) |
1.4 | 5.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.4 | 7.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
1.4 | 11.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.4 | 7.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.4 | 11.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.4 | 2.9 | GO:0048199 | vesicle coating(GO:0006901) vesicle targeting, to, from or within Golgi(GO:0048199) |
1.4 | 8.6 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.4 | 2.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.4 | 2.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
1.4 | 38.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
1.4 | 10.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.4 | 4.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.4 | 5.7 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.4 | 1.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.4 | 9.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.4 | 4.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.4 | 4.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.4 | 1.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
1.4 | 4.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.4 | 4.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.4 | 2.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.4 | 8.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.4 | 8.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.4 | 1.4 | GO:1901889 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
1.4 | 2.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
1.4 | 5.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.4 | 1.4 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.4 | 4.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.4 | 2.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.4 | 2.8 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.4 | 1.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.4 | 23.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
1.4 | 2.8 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
1.4 | 5.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.4 | 1.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.4 | 72.1 | GO:0006413 | translational initiation(GO:0006413) |
1.4 | 4.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.4 | 8.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
1.4 | 21.9 | GO:0006400 | tRNA modification(GO:0006400) |
1.4 | 4.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.4 | 19.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.4 | 2.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.4 | 6.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.4 | 1.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.4 | 9.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.4 | 1.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.4 | 2.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.4 | 5.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.4 | 2.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.4 | 5.4 | GO:0007031 | peroxisome organization(GO:0007031) |
1.4 | 8.1 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.4 | 1.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
1.4 | 2.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
1.4 | 5.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.3 | 1.3 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.3 | 6.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.3 | 20.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.3 | 4.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.3 | 14.7 | GO:1902100 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
1.3 | 9.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
1.3 | 8.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.3 | 4.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.3 | 6.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.3 | 13.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.3 | 1.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.3 | 4.0 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.3 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.3 | 1.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.3 | 3.9 | GO:0033363 | secretory granule organization(GO:0033363) |
1.3 | 2.6 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
1.3 | 14.4 | GO:0006465 | signal peptide processing(GO:0006465) |
1.3 | 2.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.3 | 3.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 9.2 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.3 | 3.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.3 | 3.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.3 | 3.9 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
1.3 | 1.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.3 | 5.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.3 | 10.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.3 | 2.6 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
1.3 | 6.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.3 | 1.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.3 | 2.6 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
1.3 | 6.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.3 | 6.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.3 | 3.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.3 | 15.5 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
1.3 | 20.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.3 | 16.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.3 | 3.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.3 | 39.8 | GO:0000045 | autophagosome assembly(GO:0000045) |
1.3 | 5.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
1.3 | 5.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.3 | 2.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.3 | 3.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.3 | 1.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
1.3 | 2.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.3 | 2.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
1.3 | 13.9 | GO:0006298 | mismatch repair(GO:0006298) |
1.3 | 5.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.3 | 2.5 | GO:0048308 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
1.3 | 2.5 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.3 | 5.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.2 | 2.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 3.7 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
1.2 | 2.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.2 | 2.5 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.2 | 2.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.2 | 3.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.2 | 28.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.2 | 11.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.2 | 7.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.2 | 2.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.2 | 4.9 | GO:0031297 | replication fork processing(GO:0031297) |
1.2 | 6.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.2 | 3.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
1.2 | 3.7 | GO:0046931 | pore complex assembly(GO:0046931) |
1.2 | 3.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.2 | 2.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
1.2 | 4.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.2 | 3.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 4.9 | GO:0080009 | mRNA methylation(GO:0080009) |
1.2 | 6.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.2 | 4.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
1.2 | 6.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.2 | 2.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.2 | 8.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.2 | 2.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.2 | 3.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.2 | 12.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
1.2 | 4.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.2 | 8.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.2 | 3.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.2 | 7.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.2 | 3.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
1.2 | 7.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
1.2 | 1.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.2 | 26.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
1.2 | 2.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.2 | 2.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.2 | 2.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 14.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.2 | 1.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.2 | 7.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.2 | 2.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
1.2 | 8.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.2 | 4.7 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
1.2 | 2.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.2 | 8.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
1.2 | 2.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
1.2 | 5.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.2 | 2.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.2 | 25.5 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
1.2 | 4.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.2 | 7.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.2 | 3.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.2 | 4.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.2 | 38.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
1.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 1.2 | GO:0006101 | citrate metabolic process(GO:0006101) |
1.2 | 2.3 | GO:0051029 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
1.1 | 1.1 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
1.1 | 4.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.1 | 1.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.1 | 1.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.1 | 2.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.1 | 5.7 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.1 | 3.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 34.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.1 | 2.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.1 | 41.9 | GO:0007041 | lysosomal transport(GO:0007041) |
1.1 | 9.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
1.1 | 1.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.1 | 2.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.1 | 9.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.1 | 6.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.1 | 3.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.1 | 3.4 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) |
1.1 | 4.5 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.1 | 8.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.1 | 2.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.1 | 3.3 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.1 | 5.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.1 | 1.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.1 | 134.6 | GO:0008380 | RNA splicing(GO:0008380) |
1.1 | 10.0 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 3.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.1 | 8.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.1 | 3.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.1 | 1.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.1 | 16.5 | GO:0006396 | RNA processing(GO:0006396) |
1.1 | 5.5 | GO:0021764 | amygdala development(GO:0021764) |
1.1 | 4.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
1.1 | 7.7 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
1.1 | 2.2 | GO:2001046 | negative regulation of hepatocyte proliferation(GO:2000346) positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.1 | 26.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
1.1 | 2.2 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.1 | 5.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.1 | 4.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
1.1 | 2.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
1.1 | 6.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.1 | 39.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.1 | 2.2 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
1.1 | 1.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
1.1 | 6.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.1 | 3.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.1 | 2.1 | GO:0001302 | replicative cell aging(GO:0001302) |
1.1 | 11.8 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.1 | 23.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
1.1 | 1.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
1.1 | 3.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.1 | 3.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.1 | 1.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.1 | 2.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.1 | 1.1 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
1.1 | 10.6 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
1.1 | 2.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.1 | 4.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.1 | 28.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
1.0 | 2.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.0 | 10.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.0 | 2.1 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) hydrogen sulfide biosynthetic process(GO:0070814) |
1.0 | 4.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
1.0 | 3.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.0 | 5.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.0 | 6.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.0 | 11.4 | GO:0051601 | exocyst localization(GO:0051601) |
1.0 | 17.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
1.0 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.0 | 3.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.0 | 30.6 | GO:0007030 | Golgi organization(GO:0007030) |
1.0 | 4.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.0 | 1.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.0 | 8.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.0 | 1.0 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
1.0 | 6.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.0 | 1.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.0 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.0 | 1.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
1.0 | 1.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.0 | 7.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.0 | 5.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.0 | 1.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.0 | 3.0 | GO:0000087 | mitotic M phase(GO:0000087) |
1.0 | 5.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.0 | 3.0 | GO:0006983 | ER overload response(GO:0006983) |
1.0 | 4.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.0 | 5.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.0 | 3.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 4.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
1.0 | 1.0 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) negative regulation of tumor necrosis factor secretion(GO:1904468) tumor necrosis factor secretion(GO:1990774) |
1.0 | 3.0 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.0 | 1.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
1.0 | 16.8 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
1.0 | 3.0 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
1.0 | 2.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.0 | 4.9 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
1.0 | 2.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.0 | 2.9 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.0 | 2.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.0 | 3.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.0 | 3.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 4.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 1.9 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.0 | 1.9 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.0 | 2.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.0 | 2.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.0 | 1.9 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.0 | 3.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.0 | 12.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.0 | 5.8 | GO:0048753 | pigment granule organization(GO:0048753) |
1.0 | 1.9 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.0 | 3.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.0 | 2.9 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
1.0 | 11.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.0 | 1.9 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
1.0 | 5.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.0 | 11.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.0 | 2.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 6.7 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.0 | 2.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.0 | 4.8 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
1.0 | 10.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
1.0 | 2.9 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.0 | 4.8 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
1.0 | 2.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.0 | 1.9 | GO:0031269 | pseudopodium assembly(GO:0031269) |
1.0 | 16.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
1.0 | 1.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.0 | 7.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.9 | 2.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.9 | 8.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.9 | 0.9 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.9 | 8.5 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.9 | 1.9 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.9 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.9 | 6.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.9 | 3.8 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.9 | 1.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.9 | 1.9 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.9 | 20.7 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.9 | 5.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.9 | 2.8 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.9 | 0.9 | GO:0030575 | nuclear body organization(GO:0030575) |
0.9 | 3.7 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.9 | 1.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.9 | 5.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.9 | 26.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.9 | 0.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.9 | 6.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.9 | 2.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.9 | 5.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.9 | 1.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.9 | 0.9 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.9 | 1.8 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.9 | 3.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.9 | 1.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.9 | 0.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.9 | 1.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.9 | 1.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.9 | 2.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 4.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.9 | 2.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.9 | 2.7 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.9 | 2.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 2.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.9 | 6.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.9 | 1.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.9 | 8.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.9 | 1.8 | GO:0046689 | response to mercury ion(GO:0046689) |
0.9 | 2.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 8.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.9 | 5.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.9 | 8.0 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.9 | 1.8 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.9 | 2.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.9 | 0.9 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.9 | 1.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.9 | 5.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.9 | 0.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.9 | 3.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.9 | 14.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.9 | 2.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.9 | 1.7 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.9 | 0.9 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.9 | 7.8 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.9 | 6.1 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.9 | 12.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.9 | 0.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.9 | 0.9 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.9 | 11.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.9 | 3.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.9 | 2.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.9 | 1.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.9 | 3.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 1.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.8 | 1.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.8 | 5.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.8 | 0.8 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.8 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 3.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 3.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.8 | 3.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 1.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.8 | 4.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.8 | 2.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 2.5 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.8 | 1.7 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.8 | 15.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.8 | 3.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.8 | 3.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.8 | 35.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.8 | 5.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.8 | 1.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.8 | 0.8 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.8 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.8 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 6.5 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.8 | 5.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.8 | 2.4 | GO:0009838 | abscission(GO:0009838) |
0.8 | 4.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.8 | 1.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.8 | 16.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.8 | 5.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.8 | 45.4 | GO:0006457 | protein folding(GO:0006457) |
0.8 | 3.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 0.8 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.8 | 1.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.8 | 12.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.8 | 3.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 4.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 4.0 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.8 | 1.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.8 | 8.8 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.8 | 5.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.8 | 4.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.8 | 4.0 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.8 | 4.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 0.8 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.8 | 3.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.8 | 1.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.8 | 20.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.8 | 6.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.8 | 2.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.8 | 6.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.8 | 2.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.8 | 24.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.8 | 7.0 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.8 | 12.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.8 | 0.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 0.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.8 | 0.8 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.8 | 2.3 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.8 | 2.3 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.8 | 1.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 9.2 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.8 | 4.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.8 | 0.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.8 | 2.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.8 | 5.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 5.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.8 | 2.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.8 | 1.5 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.8 | 2.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.8 | 3.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.8 | 4.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.7 | 2.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 3.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.7 | 0.7 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.7 | 1.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 6.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.7 | 8.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.7 | 0.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.7 | 11.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.7 | 4.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.7 | 10.3 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.7 | 5.2 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.7 | 0.7 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 3.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.7 | 1.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.7 | 3.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.7 | 0.7 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.7 | 1.5 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.7 | 2.9 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.7 | 2.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.7 | 2.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.7 | 1.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 0.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.7 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 2.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.7 | 2.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.7 | 11.5 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.7 | 2.9 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.7 | 4.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.7 | 0.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.7 | 4.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.7 | 1.4 | GO:0050955 | thermoception(GO:0050955) |
0.7 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
0.7 | 2.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.7 | 2.8 | GO:0032329 | serine transport(GO:0032329) |
0.7 | 5.7 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.7 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.7 | 4.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.7 | 2.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.7 | 9.1 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.7 | 1.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.7 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.7 | 1.4 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.7 | 32.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.7 | 0.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.7 | 0.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.7 | 7.6 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.7 | 0.7 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 4.2 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.7 | 2.1 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.7 | 0.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.7 | 3.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.7 | 4.1 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.7 | 19.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.7 | 6.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.7 | 0.7 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.7 | 0.7 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.7 | 1.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.7 | 5.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.7 | 0.7 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.7 | 1.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.7 | 10.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.7 | 0.7 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.7 | 3.4 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.7 | 1.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.7 | 0.7 | GO:0090344 | negative regulation of cell aging(GO:0090344) negative regulation of cellular senescence(GO:2000773) |
0.7 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.7 | 6.7 | GO:0019915 | lipid storage(GO:0019915) |
0.7 | 1.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.7 | 0.7 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.7 | 0.7 | GO:0070988 | demethylation(GO:0070988) |
0.7 | 20.4 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.7 | 2.6 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.7 | 7.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.7 | 3.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.7 | 7.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.7 | 3.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.7 | 8.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 2.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.7 | 1.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.7 | 3.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.6 | 1.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.6 | 1.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 2.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 3.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 1.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 9.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.6 | 4.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.6 | 2.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.6 | 1.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.6 | 1.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.6 | 3.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.6 | 0.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 1.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 4.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.6 | 1.3 | GO:0006681 | glycosylceramide metabolic process(GO:0006677) galactosylceramide metabolic process(GO:0006681) |
0.6 | 1.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.6 | 5.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.6 | 0.6 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.6 | 4.4 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.6 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 3.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.6 | 2.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 1.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.6 | 1.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 0.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 1.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.6 | 2.4 | GO:0015871 | choline transport(GO:0015871) |
0.6 | 0.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.6 | 5.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.6 | 6.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.6 | 1.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.6 | 3.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 6.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.6 | 0.6 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.6 | 0.6 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.6 | 2.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.6 | 1.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.6 | 16.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.6 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 5.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 33.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.6 | 3.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.6 | 2.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.6 | 2.4 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.6 | 1.2 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.6 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 0.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 1.2 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.6 | 1.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.6 | 7.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.6 | 2.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.6 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.6 | 1.7 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.6 | 1.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.6 | 0.6 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.6 | 1.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.6 | 1.7 | GO:0035425 | autocrine signaling(GO:0035425) |
0.6 | 0.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.6 | 0.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 0.6 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.6 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 2.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.6 | 1.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 0.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.6 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.6 | 1.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.5 | 2.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 4.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 2.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 1.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.5 | 8.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 1.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.5 | 1.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 0.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.5 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.5 | 1.1 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.5 | 1.1 | GO:0034162 | toll-like receptor 7 signaling pathway(GO:0034154) toll-like receptor 9 signaling pathway(GO:0034162) |
0.5 | 14.0 | GO:0006397 | mRNA processing(GO:0006397) |
0.5 | 3.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.5 | 0.5 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.5 | 5.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.5 | 1.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 1.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.5 | 1.6 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.5 | 2.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 3.7 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.5 | 1.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 1.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 1.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 2.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 4.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 5.2 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.5 | 7.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.5 | 2.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.5 | 3.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.5 | 1.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 | 6.2 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.5 | 1.0 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.5 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 0.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.5 | 0.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.5 | 1.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 2.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 2.5 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.5 | 1.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.5 | 0.5 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.5 | 1.5 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.5 | 2.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 1.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.5 | 1.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 4.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 2.0 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.5 | 1.5 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.5 | 2.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 18.8 | GO:0051297 | centrosome organization(GO:0051297) |
0.5 | 0.5 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.5 | 1.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 2.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 3.9 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.5 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.5 | 4.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.5 | 1.9 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.5 | 1.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.5 | 4.4 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.5 | 1.9 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.5 | 28.0 | GO:0016568 | chromatin modification(GO:0016568) |
0.5 | 1.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.5 | 1.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 4.3 | GO:1901998 | toxin transport(GO:1901998) |
0.5 | 4.8 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.5 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 0.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.5 | 0.9 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.5 | 1.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 3.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.5 | 0.9 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 1.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 1.4 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.5 | 0.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 0.5 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.5 | 0.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 1.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 0.5 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.5 | 1.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 0.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.5 | 3.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.5 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.5 | 3.6 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.5 | 51.7 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.5 | 0.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.8 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.5 | 0.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 0.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.4 | 0.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.4 | 0.4 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 5.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.4 | 1.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 8.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 1.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 1.3 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 0.9 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 3.1 | GO:0045333 | cellular respiration(GO:0045333) |
0.4 | 1.7 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.4 | 0.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.4 | 13.3 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.4 | 3.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 0.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 2.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 | 7.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 1.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.4 | 1.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.4 | 2.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.4 | 1.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.4 | 1.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 2.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.4 | 0.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.4 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 2.5 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.4 | 3.4 | GO:0046464 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.4 | 9.6 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 1.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 1.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 14.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.4 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.4 | 1.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.4 | 1.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 1.2 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.4 | 0.4 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
0.4 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 0.8 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 0.8 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 0.4 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.4 | 3.7 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.4 | 2.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.4 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 0.4 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.4 | 0.8 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.4 | 1.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 0.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 3.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.4 | 0.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.4 | 0.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 1.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.4 | 2.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 10.6 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.4 | 0.8 | GO:0051642 | centrosome localization(GO:0051642) |
0.4 | 5.1 | GO:0016575 | histone deacetylation(GO:0016575) |
0.4 | 0.4 | GO:0031579 | membrane raft organization(GO:0031579) |
0.4 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 1.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.4 | 3.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 1.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.4 | 4.3 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.4 | 17.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.4 | 0.4 | GO:0044346 | fibroblast apoptotic process(GO:0044346) regulation of fibroblast apoptotic process(GO:2000269) |
0.4 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 1.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 0.4 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.4 | 1.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 0.8 | GO:0006304 | DNA modification(GO:0006304) |
0.4 | 0.8 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.4 | 1.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.4 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.4 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 14.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.4 | 0.7 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.4 | 1.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 0.4 | GO:0036503 | ERAD pathway(GO:0036503) |
0.4 | 0.4 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 0.4 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 0.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.4 | 0.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.4 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 1.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.4 | 1.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 1.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 1.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 7.0 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.3 | 0.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 1.7 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.3 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.3 | 6.3 | GO:0031497 | chromatin assembly(GO:0031497) |
0.3 | 3.5 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.3 | 0.3 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.3 | 1.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 1.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 1.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 3.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.3 | 4.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.3 | 1.4 | GO:0022406 | membrane docking(GO:0022406) |
0.3 | 0.7 | GO:0014889 | muscle atrophy(GO:0014889) |
0.3 | 3.4 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.3 | 2.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.3 | 1.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 4.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.3 | 0.3 | GO:0072529 | pyrimidine-containing compound catabolic process(GO:0072529) |
0.3 | 4.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.3 | 2.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.3 | 1.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.3 | 0.3 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.3 | 1.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.3 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 8.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.3 | 2.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 3.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.3 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 1.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 0.6 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.3 | 1.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 52.0 | GO:0006412 | translation(GO:0006412) |
0.3 | 1.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 1.6 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
0.3 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.3 | 1.5 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 2.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.3 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 2.5 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.3 | 0.9 | GO:0003094 | glomerular filtration(GO:0003094) |
0.3 | 0.9 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 0.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 2.4 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.3 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 3.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 13.8 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.3 | 4.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 1.2 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.3 | 0.3 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.3 | 26.8 | GO:0032259 | methylation(GO:0032259) |
0.3 | 0.9 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.3 | 14.2 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.3 | 0.3 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 0.9 | GO:0090342 | regulation of cell aging(GO:0090342) |
0.3 | 28.5 | GO:0042384 | cilium assembly(GO:0042384) |
0.3 | 2.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.3 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 5.2 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 0.6 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.3 | 26.5 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.3 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.3 | 0.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.8 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 1.1 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 3.1 | GO:0097484 | dendrite extension(GO:0097484) |
0.3 | 1.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 0.6 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 0.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 1.4 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.3 | 3.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 0.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 0.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 7.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.3 | 0.3 | GO:0098751 | osteoclast development(GO:0036035) bone cell development(GO:0098751) |
0.3 | 0.3 | GO:0097468 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.3 | 2.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 13.3 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.3 | 0.3 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.3 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 1.1 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.3 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 0.3 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 0.8 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.3 | 0.8 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.5 | GO:0006323 | DNA packaging(GO:0006323) |
0.3 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 1.2 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) putrescine biosynthetic process(GO:0009446) |
0.2 | 2.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.2 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 0.7 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 1.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 3.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.2 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.2 | 3.6 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 1.7 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.2 | 0.7 | GO:1904385 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 1.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 2.0 | GO:0007034 | vacuolar transport(GO:0007034) |
0.2 | 3.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 0.2 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) |
0.2 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 1.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 1.1 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 4.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.2 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.6 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 3.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 14.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 1.7 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 3.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.2 | 0.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.2 | 0.4 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.2 | 1.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.2 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.2 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.2 | 1.0 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.2 | 0.2 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.2 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.9 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.2 | 0.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.4 | GO:0061437 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
0.2 | 0.2 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 3.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.2 | 0.7 | GO:0048806 | genitalia development(GO:0048806) |
0.2 | 0.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.2 | 1.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.2 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.7 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.2 | 5.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 0.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 48.0 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.2 | 0.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.3 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.2 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.2 | GO:1900222 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of beta-amyloid clearance(GO:1900222) |
0.2 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 1.5 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 2.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.5 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.2 | 0.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 1.0 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.2 | 0.5 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 1.1 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.2 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.3 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.8 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.3 | GO:1903201 | regulation of oxidative stress-induced cell death(GO:1903201) |
0.2 | 15.2 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
0.1 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 1.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.3 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.1 | 0.3 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 4.1 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.9 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 2.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 2.2 | GO:0002685 | regulation of leukocyte migration(GO:0002685) |
0.1 | 0.3 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 0.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 5.1 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.6 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.6 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.7 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.7 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.2 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 0.1 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.1 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.1 | 0.8 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.1 | 0.2 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 1.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.8 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.5 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.8 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:1904994 | regulation of leukocyte tethering or rolling(GO:1903236) regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.1 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.4 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.1 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.1 | 1.4 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 1.4 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.1 | 0.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.1 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.8 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.1 | 0.2 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.2 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.1 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.1 | 102.0 | GO:0090304 | nucleic acid metabolic process(GO:0090304) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.2 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.7 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 1.1 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0060592 | mammary gland formation(GO:0060592) |
0.1 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.1 | 1.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0007135 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.1 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 2.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.1 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 1.0 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.1 | 1.0 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.0 | 0.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0070231 | T cell apoptotic process(GO:0070231) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0035272 | exocrine system development(GO:0035272) |
0.0 | 0.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.9 | GO:0009636 | response to toxic substance(GO:0009636) |
0.0 | 0.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.0 | GO:0071696 | ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.2 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 3.1 | GO:0006897 | endocytosis(GO:0006897) |
0.0 | 0.2 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.0 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.0 | 0.0 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
0.0 | 2.7 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.0 | 0.3 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.0 | 0.9 | GO:0016485 | protein processing(GO:0016485) |
0.0 | 0.1 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway(GO:2001242) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 1.2 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.0 | 0.3 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 4.8 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 16.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
5.3 | 21.2 | GO:0071797 | LUBAC complex(GO:0071797) |
5.2 | 15.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
5.0 | 5.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
4.6 | 23.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
4.5 | 13.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
4.5 | 13.5 | GO:0036396 | MIS complex(GO:0036396) |
4.2 | 16.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
4.1 | 12.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
4.0 | 23.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
3.9 | 11.7 | GO:0097443 | sorting endosome(GO:0097443) |
3.8 | 11.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
3.8 | 11.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
3.8 | 3.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
3.7 | 14.8 | GO:0000938 | GARP complex(GO:0000938) |
3.7 | 22.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
3.6 | 21.8 | GO:0071986 | Ragulator complex(GO:0071986) |
3.6 | 10.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
3.5 | 10.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
3.5 | 35.2 | GO:0005687 | U4 snRNP(GO:0005687) |
3.3 | 10.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.2 | 22.5 | GO:0030008 | TRAPP complex(GO:0030008) |
3.2 | 9.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
3.1 | 44.0 | GO:0031011 | Ino80 complex(GO:0031011) |
3.1 | 9.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.1 | 9.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
3.1 | 3.1 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
3.0 | 29.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.0 | 17.9 | GO:0097346 | INO80-type complex(GO:0097346) |
3.0 | 8.9 | GO:0031417 | NatC complex(GO:0031417) |
2.9 | 40.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
2.9 | 2.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.9 | 5.8 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
2.9 | 22.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
2.8 | 22.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
2.8 | 5.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.8 | 8.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
2.8 | 8.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.8 | 8.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
2.8 | 11.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.8 | 13.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
2.8 | 11.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
2.7 | 13.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
2.7 | 30.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
2.7 | 24.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
2.7 | 16.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
2.7 | 13.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
2.7 | 10.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.7 | 23.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
2.6 | 7.9 | GO:0031084 | BLOC-2 complex(GO:0031084) |
2.6 | 10.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
2.6 | 10.5 | GO:0070876 | SOSS complex(GO:0070876) |
2.6 | 7.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
2.6 | 15.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
2.6 | 20.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
2.6 | 23.0 | GO:0005682 | U5 snRNP(GO:0005682) |
2.6 | 12.8 | GO:0089701 | U2AF(GO:0089701) |
2.6 | 7.7 | GO:0005745 | m-AAA complex(GO:0005745) |
2.5 | 17.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.5 | 12.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
2.5 | 17.5 | GO:0031931 | TORC1 complex(GO:0031931) |
2.5 | 25.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
2.5 | 7.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
2.4 | 19.6 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
2.4 | 12.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
2.4 | 9.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.4 | 7.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
2.4 | 7.1 | GO:1990393 | 3M complex(GO:1990393) |
2.3 | 9.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.3 | 16.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
2.3 | 9.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.3 | 14.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.3 | 18.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.3 | 18.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
2.3 | 6.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.3 | 9.2 | GO:0000125 | PCAF complex(GO:0000125) |
2.3 | 80.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
2.3 | 59.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
2.3 | 6.8 | GO:0097413 | Lewy body(GO:0097413) |
2.3 | 11.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.3 | 54.2 | GO:0032040 | small-subunit processome(GO:0032040) |
2.2 | 9.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
2.2 | 20.0 | GO:0000124 | SAGA complex(GO:0000124) |
2.2 | 13.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.2 | 8.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
2.2 | 26.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
2.2 | 15.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
2.2 | 13.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.2 | 17.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
2.1 | 21.2 | GO:0032039 | integrator complex(GO:0032039) |
2.1 | 8.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
2.1 | 25.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
2.1 | 6.3 | GO:0042585 | germinal vesicle(GO:0042585) |
2.1 | 23.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
2.1 | 6.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.1 | 10.3 | GO:0061617 | MICOS complex(GO:0061617) |
2.1 | 6.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.0 | 16.4 | GO:0000974 | Prp19 complex(GO:0000974) |
2.0 | 2.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.0 | 4.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.0 | 4.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.0 | 4.1 | GO:0097427 | microtubule bundle(GO:0097427) |
2.0 | 28.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.0 | 13.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.0 | 43.6 | GO:0022624 | proteasome accessory complex(GO:0022624) |
2.0 | 5.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
2.0 | 15.8 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
2.0 | 7.8 | GO:0000796 | condensin complex(GO:0000796) |
1.9 | 36.8 | GO:0015030 | Cajal body(GO:0015030) |
1.9 | 17.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.9 | 24.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
1.9 | 13.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
1.9 | 7.6 | GO:0097433 | dense body(GO:0097433) |
1.9 | 21.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.9 | 15.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.9 | 9.5 | GO:0042587 | glycogen granule(GO:0042587) |
1.9 | 3.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.9 | 15.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.9 | 35.6 | GO:0045120 | pronucleus(GO:0045120) |
1.9 | 7.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.9 | 5.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.9 | 16.8 | GO:0005869 | dynactin complex(GO:0005869) |
1.9 | 9.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.9 | 1.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.8 | 14.8 | GO:0034464 | BBSome(GO:0034464) |
1.8 | 5.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
1.8 | 49.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.8 | 3.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.8 | 25.6 | GO:0001891 | phagocytic cup(GO:0001891) |
1.8 | 12.8 | GO:0033263 | CORVET complex(GO:0033263) |
1.8 | 9.1 | GO:0034709 | methylosome(GO:0034709) |
1.8 | 9.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.8 | 79.0 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.8 | 111.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.8 | 10.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.8 | 28.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.7 | 7.0 | GO:0030897 | HOPS complex(GO:0030897) |
1.7 | 3.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.7 | 13.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.7 | 8.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
1.7 | 82.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.7 | 5.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.7 | 5.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.7 | 10.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.7 | 21.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.7 | 6.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.7 | 5.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.7 | 6.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.7 | 5.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.7 | 3.3 | GO:0097255 | R2TP complex(GO:0097255) |
1.7 | 10.0 | GO:0070820 | tertiary granule(GO:0070820) |
1.7 | 5.0 | GO:0000346 | transcription export complex(GO:0000346) |
1.7 | 1.7 | GO:0061574 | ASAP complex(GO:0061574) |
1.7 | 5.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.7 | 39.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.7 | 14.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.7 | 14.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.6 | 14.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.6 | 9.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.6 | 3.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.6 | 26.1 | GO:0035861 | site of double-strand break(GO:0035861) |
1.6 | 4.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.6 | 8.2 | GO:0001650 | fibrillar center(GO:0001650) |
1.6 | 61.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.6 | 3.2 | GO:0005686 | U2 snRNP(GO:0005686) |
1.6 | 21.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.6 | 8.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.6 | 4.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.6 | 6.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.6 | 11.2 | GO:0031209 | SCAR complex(GO:0031209) |
1.6 | 28.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.6 | 1.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.6 | 6.4 | GO:0072487 | MSL complex(GO:0072487) |
1.6 | 11.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.6 | 9.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.6 | 22.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.6 | 1.6 | GO:0030478 | actin cap(GO:0030478) |
1.6 | 15.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.6 | 12.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.5 | 17.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.5 | 21.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.5 | 60.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.5 | 4.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.5 | 53.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
1.5 | 7.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
1.5 | 6.1 | GO:0098536 | deuterosome(GO:0098536) |
1.5 | 10.7 | GO:0005795 | Golgi stack(GO:0005795) |
1.5 | 32.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.5 | 121.8 | GO:0000776 | kinetochore(GO:0000776) |
1.5 | 69.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.5 | 6.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
1.5 | 24.3 | GO:0000145 | exocyst(GO:0000145) |
1.5 | 31.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.5 | 10.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.5 | 3.0 | GO:0097441 | basilar dendrite(GO:0097441) |
1.5 | 6.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.5 | 4.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.5 | 3.0 | GO:0071942 | XPC complex(GO:0071942) |
1.5 | 6.0 | GO:0042581 | specific granule(GO:0042581) |
1.5 | 4.5 | GO:0005955 | calcineurin complex(GO:0005955) |
1.5 | 4.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 11.7 | GO:0070652 | HAUS complex(GO:0070652) |
1.5 | 5.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.5 | 17.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.4 | 8.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.4 | 43.1 | GO:0000502 | proteasome complex(GO:0000502) |
1.4 | 5.7 | GO:0045298 | tubulin complex(GO:0045298) |
1.4 | 12.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.4 | 8.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
1.4 | 4.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.4 | 14.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.4 | 8.5 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
1.4 | 46.8 | GO:0016592 | mediator complex(GO:0016592) |
1.4 | 5.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
1.4 | 36.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.4 | 5.7 | GO:0042583 | chromaffin granule(GO:0042583) |
1.4 | 12.7 | GO:0005652 | nuclear lamina(GO:0005652) |
1.4 | 12.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.4 | 2.8 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.4 | 24.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.4 | 2.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.4 | 9.5 | GO:0030914 | STAGA complex(GO:0030914) |
1.4 | 115.7 | GO:0030496 | midbody(GO:0030496) |
1.4 | 14.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
1.4 | 5.4 | GO:0005827 | polar microtubule(GO:0005827) |
1.3 | 5.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
1.3 | 9.4 | GO:0016272 | prefoldin complex(GO:0016272) |
1.3 | 4.0 | GO:0043293 | apoptosome(GO:0043293) |
1.3 | 5.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.3 | 9.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.3 | 35.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.3 | 2.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.3 | 4.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.3 | 7.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.3 | 5.2 | GO:0000235 | astral microtubule(GO:0000235) |
1.3 | 6.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.3 | 24.6 | GO:0090544 | BAF-type complex(GO:0090544) |
1.3 | 3.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.3 | 2.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
1.3 | 10.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.3 | 25.7 | GO:0070469 | respiratory chain(GO:0070469) |
1.3 | 46.1 | GO:0005643 | nuclear pore(GO:0005643) |
1.3 | 55.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.3 | 5.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.3 | 10.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
1.3 | 11.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.3 | 3.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.3 | 2.5 | GO:0055087 | Ski complex(GO:0055087) |
1.3 | 3.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.3 | 1.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
1.3 | 5.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.2 | 6.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.2 | 5.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.2 | 19.9 | GO:0030904 | retromer complex(GO:0030904) |
1.2 | 3.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.2 | 26.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.2 | 11.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
1.2 | 3.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.2 | 12.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.2 | 3.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.2 | 3.6 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.2 | 18.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.2 | 3.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.2 | 2.4 | GO:0005840 | ribosome(GO:0005840) |
1.2 | 24.9 | GO:0005776 | autophagosome(GO:0005776) |
1.2 | 17.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.2 | 5.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.2 | 84.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.2 | 9.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.2 | 14.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.2 | 3.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.2 | 19.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.2 | 2.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.1 | 3.4 | GO:0032584 | growth cone membrane(GO:0032584) |
1.1 | 2.3 | GO:0030894 | replisome(GO:0030894) |
1.1 | 3.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.1 | 9.1 | GO:0002102 | podosome(GO:0002102) |
1.1 | 22.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
1.1 | 2.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.1 | 5.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 3.3 | GO:0042382 | paraspeckles(GO:0042382) |
1.1 | 8.7 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 35.6 | GO:0005811 | lipid particle(GO:0005811) |
1.1 | 6.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.1 | 3.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.1 | 12.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
1.1 | 7.4 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
1.1 | 3.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 3.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.1 | 39.0 | GO:0000922 | spindle pole(GO:0000922) |
1.0 | 7.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.0 | 2.1 | GO:1990246 | uniplex complex(GO:1990246) |
1.0 | 22.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.0 | 12.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.0 | 8.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.0 | 4.1 | GO:0030686 | 90S preribosome(GO:0030686) |
1.0 | 6.2 | GO:1990391 | DNA repair complex(GO:1990391) |
1.0 | 7.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
1.0 | 4.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
1.0 | 6.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 2.0 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.0 | 10.0 | GO:0031902 | late endosome membrane(GO:0031902) |
1.0 | 31.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.0 | 2.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.0 | 42.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.0 | 3.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.0 | 10.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.0 | 3.9 | GO:0000805 | X chromosome(GO:0000805) |
1.0 | 399.6 | GO:0005730 | nucleolus(GO:0005730) |
1.0 | 1055.1 | GO:0005739 | mitochondrion(GO:0005739) |
1.0 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 3.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 3.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.9 | 14.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.9 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.9 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 6.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.9 | 2.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 21.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.9 | 101.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.9 | 0.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.9 | 21.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.9 | 3.6 | GO:0010369 | chromocenter(GO:0010369) |
0.9 | 10.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.9 | 2.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.9 | 5.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 2.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.9 | 4.4 | GO:0071546 | pi-body(GO:0071546) |
0.9 | 9.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.9 | 2.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.9 | 6.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.9 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 1.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.8 | 0.8 | GO:0012506 | vesicle membrane(GO:0012506) |
0.8 | 2.5 | GO:0002177 | manchette(GO:0002177) |
0.8 | 1.7 | GO:0031082 | BLOC complex(GO:0031082) |
0.8 | 10.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.8 | 0.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 2.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.8 | 5.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.8 | 2.4 | GO:0008091 | spectrin(GO:0008091) |
0.8 | 6.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.8 | 18.8 | GO:0012505 | endomembrane system(GO:0012505) |
0.8 | 81.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.8 | 1.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.8 | 5.3 | GO:0043034 | costamere(GO:0043034) |
0.7 | 3.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 3.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.7 | 14.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.7 | 7.4 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 3.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.7 | 2.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 0.7 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.7 | 1.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.7 | 2.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 1.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.7 | 2.7 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 2.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.7 | 129.8 | GO:0005813 | centrosome(GO:0005813) |
0.7 | 39.2 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.7 | 31.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 2.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 99.9 | GO:1990234 | transferase complex(GO:1990234) |
0.7 | 1.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.6 | 1.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 25.6 | GO:0031975 | envelope(GO:0031975) |
0.6 | 24.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.6 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.6 | 7.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.6 | 495.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.6 | 20.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.6 | 24.4 | GO:0001726 | ruffle(GO:0001726) |
0.6 | 53.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 17.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.6 | 0.6 | GO:0005657 | replication fork(GO:0005657) |
0.6 | 2.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 76.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.6 | 4.6 | GO:0042599 | lamellar body(GO:0042599) |
0.6 | 5.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 1.7 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 3.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 1.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 2.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 2.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.6 | 5.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 34.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.5 | 3.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 1.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 11.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.5 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.5 | 5.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 282.7 | GO:0005829 | cytosol(GO:0005829) |
0.5 | 5.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 8.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.5 | 1.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 6.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 6.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.5 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.5 | 66.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.4 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 4.0 | GO:0032420 | stereocilium(GO:0032420) |
0.4 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 7.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.4 | 1.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.4 | 3.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 0.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 0.4 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.4 | 9.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.4 | 7.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 1.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 12.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 7.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 60.0 | GO:0005773 | vacuole(GO:0005773) |
0.3 | 1.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 0.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 0.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 675.3 | GO:0005634 | nucleus(GO:0005634) |
0.3 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 11.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 1.2 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 2.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.3 | 2.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 1.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 112.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 10.0 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.2 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.0 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.2 | 0.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 4.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 2.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 2.6 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 252.5 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 2.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 3.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
5.0 | 14.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
4.8 | 14.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
4.4 | 13.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
4.4 | 4.4 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
4.1 | 4.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
4.1 | 12.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
4.1 | 12.2 | GO:0019961 | interferon binding(GO:0019961) |
4.0 | 16.2 | GO:0032564 | dATP binding(GO:0032564) |
4.0 | 4.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
3.9 | 15.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
3.9 | 11.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.9 | 11.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
3.8 | 26.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.8 | 7.6 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
3.8 | 15.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
3.6 | 14.4 | GO:0043515 | kinetochore binding(GO:0043515) |
3.6 | 14.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.5 | 3.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
3.5 | 14.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
3.5 | 13.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
3.5 | 17.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
3.4 | 10.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.4 | 27.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
3.4 | 13.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
3.4 | 10.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
3.4 | 3.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
3.3 | 23.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
3.3 | 9.8 | GO:0055100 | adiponectin binding(GO:0055100) |
3.3 | 65.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
3.3 | 19.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
3.2 | 12.9 | GO:0016531 | copper chaperone activity(GO:0016531) |
3.2 | 12.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
3.2 | 12.9 | GO:0036033 | mediator complex binding(GO:0036033) |
3.2 | 3.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
3.1 | 9.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
3.1 | 3.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
3.1 | 6.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
3.0 | 9.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.0 | 6.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
3.0 | 24.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
3.0 | 3.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
3.0 | 14.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
3.0 | 17.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.9 | 29.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.9 | 11.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.9 | 11.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
2.9 | 8.7 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
2.9 | 5.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.8 | 8.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.7 | 10.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
2.7 | 10.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.7 | 10.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
2.6 | 18.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
2.6 | 5.3 | GO:0050692 | DBD domain binding(GO:0050692) |
2.6 | 15.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
2.6 | 49.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
2.6 | 7.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
2.6 | 10.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
2.6 | 12.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
2.5 | 17.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.5 | 15.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
2.5 | 12.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
2.5 | 2.5 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
2.5 | 7.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.5 | 5.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
2.5 | 7.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
2.5 | 4.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
2.5 | 7.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.4 | 7.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.4 | 22.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
2.4 | 4.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
2.4 | 12.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
2.4 | 9.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.4 | 7.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.4 | 16.9 | GO:0000339 | RNA cap binding(GO:0000339) |
2.4 | 9.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.4 | 9.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.4 | 7.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.4 | 14.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
2.3 | 7.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
2.3 | 2.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
2.3 | 4.7 | GO:0050733 | RS domain binding(GO:0050733) |
2.3 | 11.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
2.3 | 6.9 | GO:0017069 | snRNA binding(GO:0017069) |
2.3 | 2.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.3 | 6.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.3 | 110.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
2.3 | 2.3 | GO:0030911 | TPR domain binding(GO:0030911) |
2.3 | 22.8 | GO:0015266 | protein channel activity(GO:0015266) |
2.2 | 9.0 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.2 | 11.2 | GO:0070728 | leucine binding(GO:0070728) |
2.2 | 13.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
2.2 | 6.6 | GO:0050693 | LBD domain binding(GO:0050693) |
2.2 | 6.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.1 | 17.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.1 | 2.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
2.1 | 12.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.1 | 8.5 | GO:0051425 | PTB domain binding(GO:0051425) |
2.1 | 19.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.1 | 105.0 | GO:0019843 | rRNA binding(GO:0019843) |
2.1 | 12.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
2.1 | 52.2 | GO:0043022 | ribosome binding(GO:0043022) |
2.1 | 14.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
2.1 | 8.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.1 | 16.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.1 | 6.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.1 | 16.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.0 | 6.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.0 | 4.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
2.0 | 10.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
2.0 | 42.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
2.0 | 6.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.0 | 6.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
2.0 | 11.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
2.0 | 39.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
2.0 | 9.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.0 | 5.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.0 | 17.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.0 | 9.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.0 | 2.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.9 | 11.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.9 | 3.9 | GO:1990188 | euchromatin binding(GO:1990188) |
1.9 | 5.8 | GO:0045340 | mercury ion binding(GO:0045340) |
1.9 | 15.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.9 | 5.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.9 | 15.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.9 | 40.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.9 | 5.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.9 | 3.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.9 | 37.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
1.9 | 28.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.9 | 7.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.9 | 7.5 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
1.9 | 9.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.9 | 15.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.9 | 3.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.9 | 9.3 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.9 | 9.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.9 | 3.7 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.9 | 37.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
1.9 | 7.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.8 | 29.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.8 | 5.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.8 | 5.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.8 | 5.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.8 | 7.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.8 | 27.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.8 | 55.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
1.8 | 23.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.8 | 5.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.8 | 14.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.8 | 14.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.8 | 24.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.8 | 33.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.8 | 5.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.8 | 1.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.8 | 5.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.7 | 10.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.7 | 8.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
1.7 | 13.8 | GO:1990405 | protein antigen binding(GO:1990405) |
1.7 | 13.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.7 | 5.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.7 | 1.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.7 | 12.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.7 | 155.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
1.7 | 5.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.7 | 6.7 | GO:0009374 | biotin binding(GO:0009374) |
1.7 | 47.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.7 | 58.6 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
1.7 | 6.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.7 | 3.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.7 | 5.0 | GO:0004064 | arylesterase activity(GO:0004064) |
1.7 | 5.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
1.7 | 5.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
1.6 | 18.1 | GO:0030515 | snoRNA binding(GO:0030515) |
1.6 | 9.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.6 | 8.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.6 | 19.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.6 | 14.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.6 | 1.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.6 | 1.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.6 | 34.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.6 | 3.3 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.6 | 11.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.6 | 3.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.6 | 4.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.6 | 4.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.6 | 1.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.6 | 14.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.6 | 3.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.6 | 20.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.6 | 4.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.6 | 7.8 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
1.6 | 83.0 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
1.6 | 9.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.6 | 10.9 | GO:0034046 | poly(G) binding(GO:0034046) |
1.6 | 4.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.6 | 7.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.6 | 18.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.6 | 3.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.6 | 1.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.5 | 10.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
1.5 | 4.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.5 | 6.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.5 | 18.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.5 | 4.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.5 | 10.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.5 | 6.1 | GO:0019808 | polyamine binding(GO:0019808) |
1.5 | 36.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
1.5 | 15.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.5 | 84.8 | GO:0008565 | protein transporter activity(GO:0008565) |
1.5 | 1.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
1.5 | 12.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
1.5 | 242.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.5 | 22.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.5 | 15.0 | GO:0048156 | tau protein binding(GO:0048156) |
1.5 | 6.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.5 | 34.3 | GO:0043531 | ADP binding(GO:0043531) |
1.5 | 10.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.5 | 4.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.5 | 1.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.5 | 3.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.5 | 4.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.5 | 8.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.5 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.5 | 4.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.5 | 5.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.5 | 8.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.5 | 4.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.5 | 21.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.5 | 4.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.5 | 14.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.5 | 4.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.4 | 10.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.4 | 18.8 | GO:0000049 | tRNA binding(GO:0000049) |
1.4 | 10.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.4 | 4.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
1.4 | 10.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.4 | 4.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.4 | 12.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.4 | 2.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.4 | 78.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.4 | 10.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.4 | 7.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
1.4 | 36.9 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
1.4 | 7.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.4 | 7.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.4 | 4.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
1.4 | 11.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.4 | 8.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.4 | 43.7 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.4 | 2.8 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
1.4 | 4.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.4 | 15.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.4 | 8.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.4 | 2.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.4 | 11.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.4 | 4.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 4.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.4 | 24.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.4 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.4 | 13.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.4 | 5.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.4 | 6.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.4 | 6.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.4 | 5.5 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.4 | 2.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.4 | 8.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.4 | 8.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
1.3 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.3 | 5.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.3 | 12.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.3 | 6.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.3 | 30.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.3 | 12.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.3 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.3 | 38.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.3 | 6.7 | GO:0070513 | death domain binding(GO:0070513) |
1.3 | 4.0 | GO:0004359 | glutaminase activity(GO:0004359) |
1.3 | 6.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.3 | 5.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.3 | 2.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.3 | 19.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.3 | 3.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.3 | 3.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.3 | 2.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.3 | 9.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.3 | 26.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.3 | 3.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.3 | 9.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.3 | 2.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.3 | 16.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.3 | 5.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.3 | 29.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.3 | 3.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 3.8 | GO:0071253 | connexin binding(GO:0071253) |
1.3 | 11.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.3 | 5.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.3 | 2.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.3 | 5.1 | GO:0043559 | insulin binding(GO:0043559) |
1.3 | 6.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.3 | 8.8 | GO:0031489 | myosin V binding(GO:0031489) |
1.3 | 3.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.3 | 3.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.2 | 3.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.2 | 3.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.2 | 9.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.2 | 5.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.2 | 52.0 | GO:0019003 | GDP binding(GO:0019003) |
1.2 | 35.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 4.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.2 | 6.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.2 | 828.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
1.2 | 1.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
1.2 | 3.6 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.2 | 8.5 | GO:0031996 | thioesterase binding(GO:0031996) |
1.2 | 4.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.2 | 1.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
1.2 | 26.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.2 | 25.3 | GO:0015928 | fucosidase activity(GO:0015928) |
1.2 | 12.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.2 | 3.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.2 | 1.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
1.2 | 3.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 1.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
1.2 | 3.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.2 | 3.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
1.2 | 4.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.2 | 15.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.2 | 3.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.1 | 1.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.1 | 5.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.1 | 29.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.1 | 9.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 28.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
1.1 | 10.2 | GO:0034918 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.1 | 3.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.1 | 3.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.1 | 2.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.1 | 9.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.1 | 6.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 2.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 2.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.1 | 13.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.1 | 5.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.1 | 21.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 3.3 | GO:0070061 | fructose binding(GO:0070061) |
1.1 | 4.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.1 | 1.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
1.1 | 4.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.1 | 5.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
1.1 | 4.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
1.1 | 1.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.1 | 2.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.1 | 6.5 | GO:0030274 | LIM domain binding(GO:0030274) |
1.1 | 5.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
1.1 | 5.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.1 | 18.4 | GO:0008483 | transaminase activity(GO:0008483) |
1.1 | 30.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.1 | 4.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.1 | 19.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.1 | 3.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.1 | 5.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.1 | 5.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.0 | 3.1 | GO:0035877 | death effector domain binding(GO:0035877) |
1.0 | 8.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
1.0 | 4.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.0 | 76.8 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
1.0 | 4.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.0 | 6.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.0 | 6.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.0 | 32.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
1.0 | 10.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
1.0 | 6.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
1.0 | 7.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
1.0 | 27.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.0 | 6.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.0 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.0 | 9.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.0 | 21.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.0 | 9.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.0 | 1.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
1.0 | 1.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
1.0 | 64.2 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
1.0 | 4.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.0 | 3.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.0 | 5.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 9.8 | GO:0034062 | RNA polymerase activity(GO:0034062) |
1.0 | 1.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.0 | 26.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.0 | 12.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.0 | 8.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.0 | 2.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.0 | 19.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.0 | 2.9 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.0 | 16.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.0 | 9.6 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.9 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.9 | 2.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 11.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.9 | 16.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.9 | 1.9 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.9 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.9 | 35.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.9 | 8.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.9 | 39.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.9 | 20.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.9 | 2.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.9 | 0.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 4.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 15.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.9 | 1.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.9 | 2.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.9 | 105.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.9 | 88.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.9 | 35.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.9 | 18.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.9 | 3.5 | GO:0015288 | porin activity(GO:0015288) |
0.9 | 2.6 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.9 | 5.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.9 | 2.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 28.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.8 | 5.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.8 | 0.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.8 | 10.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.8 | 2.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.8 | 2.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 1.7 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.8 | 9.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.8 | 3.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.8 | 4.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.8 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.8 | 1.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 3.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 3.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 2.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 15.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.8 | 5.5 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.8 | 2.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 7.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 2.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 6.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 7.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.8 | 9.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 9.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 74.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 2.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.8 | 3.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 2.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.8 | 3.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.8 | 5.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.8 | 4.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.8 | 3.8 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 3.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.7 | 4.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.7 | 11.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.7 | 85.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.7 | 0.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.7 | 3.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.7 | 5.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.7 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.7 | 2.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.7 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 2.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 2.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 5.0 | GO:0052685 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.7 | 2.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.7 | 0.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.7 | 2.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.7 | 1.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 2.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 2.1 | GO:0038100 | nodal binding(GO:0038100) |
0.7 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 2.8 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 2.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 2.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.7 | 7.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.7 | 10.5 | GO:0051087 | chaperone binding(GO:0051087) |
0.7 | 2.8 | GO:0016208 | AMP binding(GO:0016208) |
0.7 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.7 | 2.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 5.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.7 | 5.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.7 | 4.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.7 | 11.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.7 | 2.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 6.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.7 | 15.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 12.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.7 | 1.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.7 | 2.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 2.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 11.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 3.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 2.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 6.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 0.7 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.7 | 3.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.7 | 0.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.7 | 8.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.7 | 50.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 14.4 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.7 | 2.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 0.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.6 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 2.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 3.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 1.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 13.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.6 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.6 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 3.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 1.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 5.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.6 | 5.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.6 | 3.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.6 | 6.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 6.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.6 | 3.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 3.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 5.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 2.4 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) 2 iron, 2 sulfur cluster binding(GO:0051537) metal cluster binding(GO:0051540) |
0.6 | 2.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 7.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.6 | 16.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.6 | 9.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.6 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 3.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 1.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 2.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.6 | 1.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 5.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 47.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.6 | 3.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 4.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 7.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 9.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.6 | 2.9 | GO:0016308 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.6 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 3.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.6 | 1.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 43.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.6 | 1.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 54.5 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.6 | 2.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 2.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 2.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 6.7 | GO:0045502 | dynein binding(GO:0045502) |
0.6 | 7.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.6 | 1.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.6 | 2.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 3.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 6.0 | GO:0009055 | electron carrier activity(GO:0009055) |
0.5 | 12.5 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.5 | 26.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 1.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.5 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 12.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.5 | 1.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 2.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.5 | 14.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.5 | 2.1 | GO:0018637 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.5 | 11.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 2.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 1.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 1.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 3.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 7.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.5 | 2.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 1.5 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 1.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.5 | 3.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.5 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 40.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.5 | 5.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 7.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 9.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.5 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 1.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.5 | 4.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 23.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.5 | 6.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.5 | 81.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.5 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 4.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 4.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 62.4 | GO:0003723 | RNA binding(GO:0003723) |
0.4 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 0.9 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 0.4 | GO:0070697 | activin receptor binding(GO:0070697) |
0.4 | 2.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 8.5 | GO:0015631 | tubulin binding(GO:0015631) |
0.4 | 1.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.4 | 1.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.4 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 1.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.4 | 2.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 2.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 1.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 5.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 4.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 41.0 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 0.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 5.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.4 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 5.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 3.1 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 3.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.4 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 5.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 16.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.4 | 3.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 1.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.4 | 1.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 1.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 3.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 3.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 1.5 | GO:0009975 | cyclase activity(GO:0009975) |
0.4 | 6.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 6.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 0.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 0.4 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.4 | 4.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 10.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 3.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 2.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.0 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 1.0 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.3 | 14.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 1.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.3 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.3 | 1.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 3.3 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 4.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 7.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.3 | 5.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 1.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 2.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.3 | 0.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 1.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 3.7 | GO:0051287 | NAD binding(GO:0051287) |
0.3 | 8.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 0.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 3.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.9 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 2.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.3 | 6.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 1.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 1.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 8.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 12.9 | GO:0016887 | ATPase activity(GO:0016887) |
0.3 | 1.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.3 | 1.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 4.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.3 | 3.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 1.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 0.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 0.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 9.0 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 3.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 2.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 0.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 1.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.2 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.2 | 2.4 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 34.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 4.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 5.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 10.5 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 2.0 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 2.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 6.7 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.2 | 0.9 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 0.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 4.2 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 2.1 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.2 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 5.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 0.4 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.2 | 2.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.6 | GO:0004937 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.2 | GO:0090484 | drug transporter activity(GO:0090484) |
0.2 | 1.9 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.2 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 3.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 3.6 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.7 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 0.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 2.1 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 3.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 0.9 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 3.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 144.8 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.2 | 34.7 | GO:0070011 | peptidase activity, acting on L-amino acid peptides(GO:0070011) |
0.2 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 1.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 54.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.2 | 4.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 1.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 4.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 1.2 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 3.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.8 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.1 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) Toll-like receptor 4 binding(GO:0035662) |
0.1 | 5.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.7 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.6 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.1 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 3.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.1 | 0.2 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 1.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.1 | GO:0016829 | lyase activity(GO:0016829) |
0.0 | 0.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 2.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 11.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 58.5 | PID MYC PATHWAY | C-MYC pathway |
2.4 | 79.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.4 | 2.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.2 | 88.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
2.0 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.9 | 7.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.8 | 42.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.7 | 43.8 | PID INSULIN PATHWAY | Insulin Pathway |
1.6 | 3.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.6 | 16.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.6 | 11.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.6 | 47.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.5 | 25.8 | PID ARF 3PATHWAY | Arf1 pathway |
1.5 | 40.4 | PID ATM PATHWAY | ATM pathway |
1.5 | 30.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.4 | 13.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.4 | 38.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.4 | 24.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.4 | 13.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.3 | 25.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.3 | 47.1 | PID AURORA B PATHWAY | Aurora B signaling |
1.3 | 45.6 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 37.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.3 | 33.8 | PID ATR PATHWAY | ATR signaling pathway |
1.3 | 12.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.3 | 17.6 | PID BARD1 PATHWAY | BARD1 signaling events |
1.2 | 17.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 7.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.2 | 3.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.2 | 3.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.2 | 52.4 | PID E2F PATHWAY | E2F transcription factor network |
1.2 | 10.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.2 | 10.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.1 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.1 | 3.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.1 | 26.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
1.1 | 26.6 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 21.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.0 | 34.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.0 | 6.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.0 | 26.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 11.0 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 26.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.0 | 2.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 10.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.9 | 7.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 26.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.9 | 20.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.9 | 32.3 | PID P73PATHWAY | p73 transcription factor network |
0.9 | 6.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.9 | 14.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 28.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.9 | 8.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.9 | 9.6 | PID FOXO PATHWAY | FoxO family signaling |
0.9 | 10.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 19.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.9 | 1.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.8 | 16.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.8 | 4.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 3.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.8 | 32.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 15.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 3.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 3.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 10.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.8 | 3.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 5.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 0.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.7 | 18.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.7 | 5.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.7 | 3.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.7 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.7 | 9.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 2.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.7 | 16.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.7 | 1.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.7 | 2.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 5.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.6 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 22.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.6 | 8.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.6 | 20.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 9.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 7.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 1.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 1.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 2.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 3.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 6.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 3.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.5 | 7.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 4.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 4.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.4 | 2.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 1.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 1.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 2.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.4 | 10.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 10.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 4.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 6.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 2.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 4.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 3.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 4.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 2.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 3.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 5.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 3.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 1.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 3.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 2.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 3.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 3.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 5.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 4.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
4.0 | 4.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
3.6 | 25.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
3.5 | 10.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.1 | 3.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
3.0 | 45.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.9 | 5.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
2.7 | 38.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
2.6 | 26.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
2.5 | 47.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
2.5 | 22.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.4 | 21.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
2.4 | 9.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
2.3 | 28.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
2.2 | 4.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
2.2 | 17.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
2.2 | 24.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.1 | 23.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
2.1 | 18.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
2.1 | 10.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
2.1 | 197.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
2.0 | 22.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
2.0 | 32.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
2.0 | 22.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.0 | 27.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
2.0 | 21.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.9 | 19.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
1.9 | 48.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.9 | 80.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.9 | 147.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.9 | 35.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
1.9 | 29.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.9 | 3.7 | REACTOME KINESINS | Genes involved in Kinesins |
1.9 | 61.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.8 | 22.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.8 | 44.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
1.8 | 5.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.8 | 24.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.8 | 27.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.8 | 1.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.8 | 20.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
1.8 | 7.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.8 | 77.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
1.8 | 32.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.8 | 39.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.8 | 21.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.8 | 46.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.8 | 21.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.8 | 22.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.7 | 64.6 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
1.7 | 12.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.7 | 19.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.7 | 36.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.7 | 23.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.7 | 80.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
1.7 | 14.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.6 | 3.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.6 | 24.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.6 | 12.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.6 | 22.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.6 | 27.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.6 | 17.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.6 | 7.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.6 | 1.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.6 | 10.9 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
1.6 | 12.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.5 | 36.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
1.5 | 32.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.5 | 24.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.5 | 19.6 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.5 | 6.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.5 | 29.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.5 | 1.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.5 | 5.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.5 | 58.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.4 | 11.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.4 | 80.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.4 | 5.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.4 | 13.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.4 | 28.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.4 | 15.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.4 | 31.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.4 | 12.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 4.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.3 | 5.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.3 | 13.5 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
1.3 | 18.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 25.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.3 | 22.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.3 | 20.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.3 | 170.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.3 | 14.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.3 | 3.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
1.3 | 15.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.2 | 43.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.2 | 14.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.2 | 7.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.2 | 8.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.2 | 19.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.2 | 23.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.2 | 4.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.2 | 10.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.2 | 2.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.2 | 21.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.2 | 19.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
1.2 | 2.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.2 | 11.5 | REACTOME TRANSLATION | Genes involved in Translation |
1.1 | 2.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 11.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.1 | 11.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.1 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
1.1 | 17.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.1 | 15.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.1 | 28.0 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
1.1 | 4.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.0 | 1.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.0 | 19.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.0 | 16.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.0 | 13.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.0 | 8.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.0 | 16.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.0 | 23.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 5.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.0 | 1.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
1.0 | 33.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.9 | 14.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 2.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.9 | 10.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.9 | 5.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.9 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.9 | 9.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 0.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.9 | 23.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.9 | 11.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 29.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 23.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.9 | 16.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.9 | 3.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.9 | 6.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.9 | 4.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.9 | 7.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 5.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.8 | 21.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.8 | 5.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.8 | 9.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 4.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.8 | 50.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.8 | 3.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.8 | 1.5 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.7 | 9.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 2.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.7 | 9.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 2.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 14.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 6.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.7 | 4.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.7 | 5.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 12.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 1.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.6 | 5.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 1.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.6 | 16.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.6 | 2.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 6.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 6.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 18.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.6 | 1.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 10.8 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.6 | 1.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 5.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.6 | 1.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.6 | 8.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 18.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.6 | 1.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 10.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.5 | 8.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.5 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 17.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 5.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 28.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 21.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 3.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 9.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.5 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 29.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 5.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 9.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 8.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 4.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 1.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 1.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 9.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 6.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 4.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 12.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 2.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 1.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 5.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 13.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.3 | 2.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 5.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.3 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 20.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 1.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 4.1 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 5.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 2.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 0.2 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 6.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 4.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.0 | 0.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |